November 3rd 2023
What is new in research on SUDs?
October 21st 2023
An expert addresses some common concerns about the drug and some effective ways clinicians can initiate the treatment at the 2023 Annual Psychiatric Times™ World CME Conference.
August 31st 2023
Today is International Overdose Awareness Day!
August 30th 2023
The funds will be distributed over the course of 5 years to support preclinical through phase 2 studies.
August 26th 2023
From informed consent in treatment with psychedelics to an anti-fentanyl antibody that may reverse the signs of carfentanil overdose, here are highlights from the week in Psychiatric Times.
What Physicians Can Learn From 'Painkiller' (2023)
The series explores the origins of the first opioid crisis in the United States.
Study Shows That Anti-Fentanyl Antibody Reverses Signs of Carfentanil Overdose
“We expect this antibody to be a valuable new weapon for fighting the opioid crisis.”
The Week in Review: June 26-30
From an examination of the fentanyl epidemic to the connection between ADHD medication and height, here are highlights from the week in Psychiatric Times.
FDA Approves First Naloxone Product for Over-the-Counter Use
The AMA, substance abuse experts share their thoughts on this decision and what it means for psychiatric clinicians and their patients.
The Week in Review: February 6-10
From the impact of patients’ overdose deaths on physicians to addressing America’s mental health crisis, here are highlights from the week in Psychiatric Times.
The Overdose Conundrum
A patient loss does not undo or discard the multitude of meaningful life changing and life preserving work done.
NDA Accepted for Nasal Nalmefene for Opioid Overdose
The FDA has accepted the NDA for nasal nalmefene, OPNT003, to treat opioid overdose.
Drug Abuse Trends and Treatment Approaches for 2023
What are the most pertinent drug trends to be aware of in 2023?
The Road to Over-the-Counter Naloxone: FDA Releases Federal Register Notice
We may be one step closer to nonprescription naloxone.
The Week in Review: October 10-14
From traumatic brain injury to the dangers of excessive social media usage, here are highlights from the week in Psychiatric Times.
Expert Sheds Light on Opioid Overdose Crisis in Youth
Opioid use, addiction, and overdose in youth continue to increase. What can be done?
Advocating for Medication for Opioid Use Disorder
The NCCHC and 166 national organizations recently signed a letter to Senate leadership advocating for increased access to buprenorphine.
My Patient Overdosed and Now I Feel Guilty…
The Overdose Epidemic and the “Astounding” Life Expectancy Drop
New data shows a decrease in life expectancy in the United States. Here’s why.
Understanding and Addressing Physician Substance Use and Misuse
“Doctors are great at hiding their addictions, especially from themselves... However, there are signs that something is wrong—be it addiction, depression, psychosis, or some other problem.”
New Webinar on Opioid Use Disorder Treatment
Do you need more information on opioid use disorder? This webinar can help.
A Whirlwind Tour of OUD Treatment Strategies
Opioid use disorder—how can we battle the epidemic of overdoses?
Buprenorphine and Its Therapeutic Potential in Psychiatric Disorders
Researchers discuss new research on buprenorphine, the “gold standard” treatment for opioid use disorder at the APA Annual Meeting.
Alleviating Opioid Use Disorder With Cognitive Behavior Therapy and Medication-Assisted Treatment
Normal Life Stress, They Say…
Recovery from addiction does not protect against normal life events...
APhA Conference Addresses Depression, Benzos
Catch up on all the latest from the American Pharmacists Association (APhA) Annual Meeting & Exposition.
Naloxone as a Tool to Fight the Opioid Epidemic
If you missed out on the custom Around the Practice video program on naloxone, we've got you covered. Read a recap here.
Cognitive Behavior Therapy and Medication-Assisted Treatment for Opioid Use Disorder
How can this combination of treatments help create positive change for individuals struggling with addiction?
Fun and Games: Improving Youth Opioid Awareness
Can a game improve children and adolescents knowledge of the opioid crisis?
Stopping the Opioid Crisis: Evidence-Based Public Health Approaches
A coalition of 240 organizations came together to urge Congress to pass legislation to fight the opioid crisis.
Risk of Overdose with Antipsychotic and Opioid Co-Prescription
Unintentional overdose with antipsychotics plus opioids. Researchers performed a population-based cohort study of the risk of overdose associated with co-prescription of antipsychotics and opioids.
The Opioid Crisis Is Neither a White Nor an Adult Problem
How can psychiatrists improve substance use treatment for Black and pediatric patients?
The AMA’s 7 Recommendations for Reducing the Opioid Crisis
The American Medical Association is urging policymakers to act now to prevent further opioid overdose deaths.
A Vaccine to Treat Opioid Disorders: First Participant Enrolled in Trial
A vaccine that prevents oxycodone from entering the brain? This might be the safe, long-lasting, cost-effective solution for opioid use disorders.
Harnessing Harm-Reduction Methods to Combat the Opioid Crisis
2 Commerce Drive Cranbury, NJ 08512